172 related articles for article (PubMed ID: 29677389)
1. Population Pharmacokinetics of Intramuscular and Intravenous Ketamine in Children.
Hornik CP; Gonzalez D; van den Anker J; Atz AM; Yogev R; Poindexter BB; Ng KC; Delmore P; Harper BL; Melloni C; Lewandowski A; Gelber C; Cohen-Wolkowiez M; Lee JH;
J Clin Pharmacol; 2018 Aug; 58(8):1092-1104. PubMed ID: 29677389
[TBL] [Abstract][Full Text] [Related]
2. Development of an optimal sampling schedule for children receiving ketamine for short-term procedural sedation and analgesia.
Sherwin CM; Stockmann C; Grimsrud K; Herd DW; Anderson BJ; Spigarelli MG
Paediatr Anaesth; 2015 Feb; 25(2):211-6. PubMed ID: 25212712
[TBL] [Abstract][Full Text] [Related]
3. Modeling the norketamine metabolite in children and the implications for analgesia.
Herd DW; Anderson BJ; Holford NH
Paediatr Anaesth; 2007 Sep; 17(9):831-40. PubMed ID: 17683400
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of S-ketamine during prolonged sedation at the pediatric intensive care unit.
Flint RB; Brouwer CNM; Kränzlin ASC; Lie-A-Huen L; Bos AP; Mathôt RAA
Paediatr Anaesth; 2017 Nov; 27(11):1098-1107. PubMed ID: 29030928
[TBL] [Abstract][Full Text] [Related]
5. Exploring the pharmacokinetics of oral ketamine in children undergoing burns procedures.
Brunette KE; Anderson BJ; Thomas J; Wiesner L; Herd DW; Schulein S
Paediatr Anaesth; 2011 Jun; 21(6):653-62. PubMed ID: 21355949
[TBL] [Abstract][Full Text] [Related]
6. Ketamine disposition in children presenting for procedural sedation and analgesia in a children's emergency department.
Herd D; Anderson BJ
Paediatr Anaesth; 2007 Jul; 17(7):622-9. PubMed ID: 17564643
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Ketamine Adult Anesthetic Doses in Pediatrics Using Pharmacokinetic Modeling and Simulations.
Elkomy MH; Alruwaili N; Elmowafy M; Shalaby K; Drover DR; Ramamoorthy C
Pharmacotherapy; 2019 Apr; 39(4):454-462. PubMed ID: 30825333
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers.
Dowling J; Isbister GK; Kirkpatrick CM; Naidoo D; Graudins A
Ther Drug Monit; 2008 Aug; 30(4):490-6. PubMed ID: 18641540
[TBL] [Abstract][Full Text] [Related]
9. Hydromorphone population pharmacokinetics in pediatric surgical patients.
Balyan R; Dong M; Pilipenko V; Geisler K; Vinks AA; Chidambaran V
Paediatr Anaesth; 2020 Oct; 30(10):1091-1101. PubMed ID: 32702184
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of ketamine following intramuscular injection to F344 rats.
Moeller B; Espelien B; Weber W; Kuehl P; Doyle-Eisele M; Garner CE; McDonald JD; Garcia E; Raulli R; Laney J
Drug Test Anal; 2019 Jan; 11(1):68-76. PubMed ID: 30027605
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.
Hahn J; Yang S; Min KL; Kim D; Jin BH; Park C; Park MS; Wi J; Chang MJ
Crit Care; 2019 Jul; 23(1):248. PubMed ID: 31288863
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetics of oxycodone: Premature neonates to adults.
Morse JD; Sundermann M; Hannam JA; Kokki H; Kokki M; Anderson BJ
Paediatr Anaesth; 2021 Dec; 31(12):1332-1339. PubMed ID: 34469607
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of hydromorphone after intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta).
Kelly KR; Pypendop BH; Christe KL
J Am Assoc Lab Anim Sci; 2014 Sep; 53(5):512-6. PubMed ID: 25255074
[TBL] [Abstract][Full Text] [Related]
14. Intranasal sufentanil/ketamine analgesia in children.
Nielsen BN; Friis SM; Rømsing J; Schmiegelow K; Anderson BJ; Ferreirós N; Labocha S; Henneberg SW
Paediatr Anaesth; 2014 Feb; 24(2):170-80. PubMed ID: 24118506
[TBL] [Abstract][Full Text] [Related]
15. Analgesic effects of caudal and intramuscular S(+)-ketamine in children.
Koinig H; Marhofer P; Krenn CG; Klimscha W; Wildling E; Erlacher W; Nikolic A; Turnheim K; Semsroth M
Anesthesiology; 2000 Oct; 93(4):976-80. PubMed ID: 11020749
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of rapacuronium in infants and children with intravenous and intramuscular administration.
Reynolds LM; Infosino A; Brown R; Hsu J; Fisher DM
Anesthesiology; 2000 Feb; 92(2):376-86. PubMed ID: 10691223
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and analgesic effects of intravenous, intramuscular or subcutaneous buprenorphine in dogs undergoing ovariohysterectomy: a randomized, prospective, masked, clinical trial.
Steagall PV; Ruel HLM; Yasuda T; Monteiro BP; Watanabe R; Evangelista MC; Beaudry F
BMC Vet Res; 2020 May; 16(1):154. PubMed ID: 32448336
[TBL] [Abstract][Full Text] [Related]
18. Model Based Estimation of Posaconazole Tablet and Suspension Bioavailability in Hospitalized Children Using Real-World Therapeutic Drug Monitoring Data in Patients Receiving Intravenous and Oral Dosing.
Kane Z; Cheng I; McGarrity O; Chiesa R; Klein N; Cortina-Borja M; Standing JF; Gastine S
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0007723. PubMed ID: 37260401
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans.
Clements JA; Nimmo WS; Grant IS
J Pharm Sci; 1982 May; 71(5):539-42. PubMed ID: 7097501
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of ketamine in children with heart disease.
Elkomy MH; Drover DR; Hammer GB; Galinkin JL; Ramamoorthy C
Int J Pharm; 2015 Jan; 478(1):223-231. PubMed ID: 25448584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
